IRVINE, CA--(Marketwire - March 19, 2009) - Edwards Lifesciences Corporation (NYSE: EW), the
world leader in the science of heart valves, announced that the District
Court of Düsseldorf, Germany, today determined that it does not infringe on
Cook Inc.'s German transcatheter valve patent.
"We are very pleased with this first infringement decision and believe our
invalidity case is even stronger," said Larry L. Wood, Edwards' corporate
vice president, transcatheter valve replacement. "Edwards has invested
substantially to assemble what we believe is the strongest and most
comprehensive intellectual property portfolio in transcatheter heart
valves, and we are committed to protecting our interests."
A counter-suit by Edwards claiming invalidity of Cook's German patent is
expected to be heard in Munich in 2010. Edwards has a separate lawsuit
against Cook in the United Kingdom that challenges the validity of Cook's
UK transcatheter valve patent. Cook has counter-sued there, claiming
infringement. That case is scheduled to be heard in May.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring, with more than five decades of experience in
partnering with clinicians to develop life-saving innovations.
Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular
disease with its market-leading heart valve therapies, and critical care
and vascular technologies, which are sold in approximately 100 countries.
The company's global brands include Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional
company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards
Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, Magna, PERIMOUNT Magna and Swan-Ganz are
trademarks of Edwards Lifesciences Corporation and are registered in the
United States Patent and Trademark Office.